Global Biotech Co. To Pay $95M In Class-Action Lawsuit
California-based global biotech company Amgen Inc. has agreed to pay $95 million to settle a class-action lawsuit filed on behalf of investors who bought securities from the company between April 2004 and May 2007, according to a statement from State Treasurer Denise L. Nappier.





